MIRM - Mirum Pharmaceuticals rises after director Patrick Heron acquires shares worth ~$257K
2023-09-14 11:46:59 ET
More on Mirum Pharmaceuticals
- Seeking Alpha’s Quant Rating on Mirum Pharmaceuticals
- Historical earnings data for Mirum Pharmaceuticals
- Financial information for Mirum Pharmaceuticals
- Mirum Pharmaceuticals, Inc. ( NASDAQ: MIRM ) Q2 2023 Earnings Call Transcript
- Mirum Pharmaceuticals, Inc. 2023 Q2 - Results - Earnings Call Presentation
- Mirum: Must Watch Biotech On Release Of Results From EMBARK Study
For further details see:
Mirum Pharmaceuticals rises after director Patrick Heron acquires shares worth ~$257K